Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.29M Sell
6,376
-2,183
-26% -$429K 0.19% 210
2017
Q2
$1.75M Buy
8,559
+627
+8% +$125K 0.25% 140
2017
Q1
$1.45M Buy
7,932
+5,104
+180% +$890K 0.28% 112
2016
Q4
$454K Sell
2,828
-2,194
-44% -$322K 0.11% 344
2016
Q3
$708K Sell
5,022
-1,990
-28% -$277K 0.15% 283
2016
Q2
$956K Sell
7,012
-1,823
-21% -$242K 0.23% 165
2016
Q1
$1.2M Buy
8,835
+842
+11% +$114K 0.32% 93
2015
Q4
$1.2M Sell
7,993
-3,770
-32% -$557K 0.34% 57
2015
Q3
$1.57M Buy
+11,763
New +$1.65M 0.36% 50

Other funds holding CHE

GAM Systematic's CHE Position: Q3 2017 in Review

GAM Systematic reduced its Chemed (CHE) stake by 26% in Q3 2017, selling an estimated $429K and leaving 6,376 shares worth $1.29M. The position accounts for 0.19% of the portfolio, ranked #210.

GAM Systematic first reported a position in CHE in Q3 2015 and has held it in 9 quarters since. The position peaked at $1.75M in Q2 2017. 259 funds tracked by Wall St. Rank hold CHE as of Q3 2017.

  • GAM Systematic held 6,376 shares of Chemed worth $1.29M as of Q3 2017.
  • GAM Systematic sold 2,183 Chemed shares in Q3 2017, an estimated $429K.
  • Chemed made up 0.19% of GAM Systematic's portfolio in Q3 2017, its #210 holding.
  • GAM Systematic first reported a position in Chemed in Q3 2015 and has held it in 9 quarters since.
  • GAM Systematic's Chemed position peaked at $1.75M in Q2 2017.
  • 259 funds tracked by Wall St. Rank held Chemed as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.